Quantify was a proud supporter of this year’s IFPA CONFERENCE 2024 where Jonas Banefelt and Nicholas Norton exhibited Quantify’s extensive research experience in psoriatic disease, including our collaborations with IFPA and a recently conducted post-authorisation safety study (PASS) in collaboration with The Janssen Pharmaceutical Companies of Johnson & Johnson.
Get in touch to find out more!
